People now have the ability to change the color of their eyes

People now have the ability to change the color of their eyes

Bailey Greenberg - Staff Writer, Photo courtesy of Google Image

Stroma Medical Corporation is now testing a new procedure that changes a person’s eye color. This procedure only takes 30 seconds and removes the thin layer of brown pigment on the human eye to turn the pigment blue. The Stroma laser removes the brown pigment that covers the surface of the iris. This laser disrupts the layer of brown pigment which causes the body to commence a natural and gradual tissue-removal process. Once the tissue is completely removed, a blue eye color is revealed. This laser procedure is non-invasive, and the full color change process should take no longer than four weeks.

“The fundamental principle is that under every brown eye is a blue eye,” said Dr. Gregg Homer in an interview with CNN. “The only difference between a brown eye and a blue eye is this very thin layer of pigment on the surface.”

Stroma Medical Corporation is a late-stage research and development company located in Laguna Beach, Calif. The inventor and scientist Gregg Homer, Doctor of Juridical Science (PhD), developed and patented this eye color-changing procedure and hopes for the surgery to have a prosperous take off in the U.S. and other countries.

According to Stroma’s website, this procedure requires no incisions or injections of any kind. There is little to no contact with the patient’s eye other than a small device to help keep the patient’s eyelids open during the procedure and an application of a mild topical medication. During the surgery, the patient sits in front of the Stroma laser while his or her head is stabilized. The patient faces his or her untreated eye toward a tiny animation. This treatment should have no effect on the patient’s vision because the Stroma laser treats only the iris. The eyes will then begin to become progressively lighter, revealing an underlying blue color.

“I believe this new eye procedure is moderately risky but might soon become the big new trend,” said junior Lucas Anderson.

This procedure is not yet available to the general public. Stroma is completing a preliminary human study to test the safety and efficiency of the procedure. The company’s next step is to complete its pilot and pivotal human clinical studies using its new device while treating 20 patients in an initial pilot study. Following Stroma’s successful completion of the pilot study, the company plans to treat 100 patients in many countries and follow those patients for a predetermined length of time. The product will be released when scientists are satisfied with the safety and efficiency of the procedure.